跳至主要内容
临床试验/NCT04217109
NCT04217109已完成不适用

KDOG1 :Transcutaneous Breast Cancer Diagnosis by Canine Odorology

Institut Curie13 个研究点 分布在 1 个国家目标入组 196 人开始时间: 2020年2月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
196
试验地点
13
主要终点
Evaluate the sensitivity and specificity of canine odorology in women with breast lesion

研究概览

简要总结

Patient with an indication of interventional percutaneous procedure for characterization of a breast lesion, palpable or not, classified as category 4 or 5, according to the Breast Imaging (BI) Report and Data System of the American College of Radiology (RADS) classification detected at mammography and/or breast ultrasound examination.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women 18 years and older, with one or more ipsilateral mammary lesion(s), palpable or not, detected at mammography and/or ultrasound and with at least one lesion classified as BI-RADS® category 4 or 5 with an indication of percutaneous sampling (cytology, microbiopsies, macro-biopsies) ;
  • Benefit from the national social security ;
  • Signature of the informed consent of the study ;
  • There is no contraindication for the person to simultaneously participate to another research program and there is no exclusion period planned after the study.

排除标准

  • Patient with bilateral breast lesions classified as BI-RADS® category 4 or 5;
  • Patient with breast implant(s);
  • Patient with a personal history of breast surgery for benign lesion(s) of the concerned breast operated less than 4 weeks before the date of inclusion in this study;
  • Patient with a personal history of cancer (in situ or invasive) less than 5 years before inclusion whatever the anatomical site including cutaneous basal cell carcinoma;
  • Patient with a personal history of punctures and/or percutaneous breast biopsies of the concerned breast less than 4 weeks before inclusion;
  • Patient with a breast skin ulceration;
  • Patient under insulin (risk of sudation that may impair compress sample);
  • Concomitant antibiotics or corticoids taken one week before inclusion in the study;
  • Patient with a current viral infection (fever);
  • Persons under guardianship or deprived of liberty;
  • Impossibility to submit to the medical monitoring expected by the study for geographical or severe psychological reasons.

结局指标

主要结局

Evaluate the sensitivity and specificity of canine odorology in women with breast lesion

时间窗: 26 months

The sensitivity and specificity of canine odorology in women with undeterminate breast lesion classified American College of Radiology (ACR) 4 or 5 (typically malignant) will be compared to the anatomopathological results of breast percutaneous sampling (biopsy)

次要结局

  • Patient compliance during the study(26 months)
  • Sensitivity (markings on patients affected) and specificity (no-markings on patients not affected)(38 months)
  • Positive predictive value (PPV) and negative predictive value (NPV) of canine odorology(38 months)
  • Comparison between canine odorology and mammography(38 months)
  • Performance of each dog(26 months)
  • Performance of canine odorology if the test is based on 2 dogs(24 months)
  • Variability between dogs(26 months)
  • Patient's satisfaction(26 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (13)

Loading locations...

相似试验